grant

Developmental Funds

Organization WISTAR INSTITUTELocation PHILADELPHIA, UNITED STATESPosted 1 Apr 1997Deadline 28 Feb 2031
NIHUS FederalResearch GrantFY2026AchievementAchievement AttainmentAgreementAnti-Cancer AgentsAntineoplastic AgentsAntineoplastic DrugsAntineoplasticsAreaAwardBasic Cancer ResearchBioinformaticsBiological AgentBiological ProductsBreast Cancer Risk FactorBudgetsBurkitt HerpesvirusBurkitt Lymphoma VirusCCSGCancer CenterCancer Center Support GrantCancer DrugCancer Research ProgramsCancer Research ProjectCancersCell Communication and SignalingCell SignalingChemicalsCollaborationsComputational BiologyDevelopmentDirect CostsEB virusEBVEpitheliumEpstein Barr VirusEvaluationFacultyFaculty RecruitmentFundingGenomeGoalsHHV-4HHV4Health SciencesHistoryHuman Herpesvirus 4ImmuneImmune signalingImmunesInfectious Mononucleosis VirusInstitutionInternationalIntracellular Communication and SignalingInvestigatorsInvestmentsJointsLaboratoriesLeadershipMachine LearningMalignant MelanomaMalignant NeoplasmsMalignant Ovarian NeoplasmMalignant Ovarian TumorMalignant TumorMalignant Tumor of the OvaryMalignant neoplasm of ovaryMelanomaMissionMolecularNCI-Designated Cancer CenterNSCLCNSCLC - Non-Small Cell Lung CancerNeoplastic Disease Chemotherapeutic AgentsNeuroendocrine Prostate CancerNon-Small Cell Lung CancerNon-Small-Cell Lung CarcinomaOncogenesisOvary CancerP01 MechanismP01 ProgramPeer ReviewPhiladelphiaPilot ProjectsPlantsPlayPriceProcessProgram Project GrantProgram Research Project GrantsPublicationsRecording of previous eventsRegulationResearchResearch PersonnelResearch PriorityResearch Program ProjectsResearch ResourcesResearchersResourcesRoleScienceScientific PublicationSerousSignal TransductionSignal Transduction SystemsSignalingStrategic PlanningTherapeuticTranslational ResearchTranslational ScienceTumor-Specific Treatment AgentsViralanti-cancer drugbiological signal transductionbiologicsbiopharmaceuticalbiotherapeutic agentbreast cancer riskcancer immunologycomputer biologydevelopmentalexperimentexperimental researchexperimental studyexperimentsfaculty supporthistoriesimmune microenvironmentimmunosuppressive microenvironmentimmunosuppressive tumor microenvironmentinnovateinnovationinnovativeinter-institutionalinterdisciplinary collaborationlead optimizationmachine based learningmalignancymemberneoplasm immunologyneoplasm/cancerovarian cancerpersonalization of treatmentpersonalized medicinepersonalized therapypersonalized treatmentpilot studypopulation healthpre-clinical developmentpreclinical developmentpricingprogramsrecruitrecruit teachersrepurposingsmall moleculesocial rolesq. ftsquare footteacher recruitmenttransdisciplinary collaborationtranslation researchtranslational investigationtumortumor immune microenvironmenttumor immunologytumor-immune system interactionstumorigenesis
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY – DEVELOPMENTAL FUNDS
The strategic allocation of Developmental Funds has played an indispensable role in advancing the mission of

the Cancer Center and its societal impact during the last Cancer Center Support Grant (CCSG) budget period.

Allocated through a consultative and transparent process that proactively engages all Cancer…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Developmental Funds — WISTAR INSTITUTE | UNITED STATES | Apr 1997 | Dev Procure